Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting: a Multicenter, Evaluator-Blind, Randomized and Controlled Trial

注册号:

Registration number:

ITMCTR2000002891

最近更新日期:

Date of Last Refreshed on:

2020-01-03

注册时间:

Date of Registration:

2020-01-03

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

经皮穴位电刺激防治术后恶心呕吐的多中心、评价者盲法随机对照临床研究

Public title:

Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting: a Multicenter, Evaluator-Blind, Randomized and Controlled Trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮穴位电刺激防治术后恶心呕吐的多中心、评价者盲法随机对照临床研究

Scientific title:

Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting: a Multicenter, Evaluator-Blind, Randomized and Controlled Trial

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000028774 ; ChiMCTR2000002891

申请注册联系人:

吕志峰

研究负责人:

方洁

Applicant:

Zhifeng Lv

Study leader:

Jie Fang

申请注册联系人电话:

Applicant telephone:

+86 13526785785

研究负责人电话:

Study leader's telephone:

+86 0371-66245047

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

mazui1846@126.com

研究负责人电子邮件:

Study leader's E-mail:

mazui1846@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

河南省郑州市人民路19号河南中医药大学第一附属医院

研究负责人通讯地址:

河南省郑州市人民路19号

Applicant address:

19 Renmin Road, Zhengzhou, He'nan, China

Study leader's address:

19 Renmin Road, Zhengzhou, He'nan, China

申请注册联系人邮政编码:

Applicant postcode:

450052

研究负责人邮政编码:

Study leader's postcode:

450052

申请人所在单位:

河南中医药大学第一附属医院

Applicant's institution:

The First Affiliated Hospital of He'nan University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2019HL-162

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

河南中医药大学第一附属医院伦理委员会

Name of the ethic committee:

Institutional Ethics Committee of the First Affiliated Hospital of He'nan University of Chinese&#3

伦理委员会批准日期:

Date of approved by ethic committee:

2019/11/22 0:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

西安交通大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Xi'an Jiaotong University

研究实施负责(组长)单位地址:

陕西省西安市雁塔西路277号

Primary sponsor's address:

277 West Yanta Road, Xi'an, Shaanxi, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南省

市(区县):

郑州市

Country:

China

Province:

He'nan

City:

Zhengzhou

单位(医院):

河南中医药大学第一附属医院

具体地址:

河南省郑州市人民路19号

Institution
hospital:

The First Affiliated Hospital of He'nan University of Chinese Medicine

Address:

19 Renmin Road

国家:

中国

省(直辖市):

陕西省

市(区县):

西安市

Country:

China

Province:

Shaanxi

City:

Xi'an

单位(医院):

西安交通大学第一附属医院

具体地址:

陕西省西安市雁塔西路277号

Institution
hospital:

The First Affiliated Hospital of Xi 'an Jiaotong University

Address:

277 West Yanta Road

经费或物资来源:

自筹

Source(s) of funding:

self-collected

研究疾病:

非胃肠道的腹腔镜手术

研究疾病代码:

Target disease:

Non-gastrointestinal laparoscopic surgery

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

IV期临床试验

Phase IV clinical trial

研究目的:

评价在规范化药物防治PONV的基础上, TEAS对术后恶心呕吐的防治效果。

Objectives of Study:

Evaluation the effect of prevention and treatment of PONV for TEAS on the postoperative.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)拟于全麻下行择期腹腔镜非胃肠手术者; (2)年龄18-50岁,BMI 15-40 kg/m2 ,ASA I-III级; (3)PONV风险度预测评分Apfel ≥3分; (4)能理解、签署知情同意书,并配合完成干预和评估者。

Inclusion criteria

1. Patients for selective laparoscopic non-gastrointestinal surgery under general anesthesia; 2. Aged 18–50 year, BMI 15-40 kg/m2, ASA,class I-III; 3. Apfel's score of PONV risk prediction >=3 points; 4. Ability to understand, sign informed consent and cooperate with the intervention and evaluation.

排除标准:

(1)怀孕、哺乳期患者; (2)经皮穴位电刺激禁忌者:试验穴位皮肤过敏、破损、感染、瘙痒等;对胶布过敏;起搏器植入者; (3)确定/怀疑有酒精、阿片类药物或其他药物滥用史; (4)术后入ICU者; (5)在入选本研究前3个月内参与其他临床研究。

Exclusion criteria:

1. Pregnancy and breast feeding women 2. TEAS contraindications: skin allergy, breakage, infection or itching of test points, allergy toadhesive tape, pacemaker implant; 3. Confirmation/suspection a history of alcohol, opioid or other drugs; 4. Admission to ICU after surgery; 5. Participation in other clinical studies within 3 months before admission to this study.

研究实施时间:

Study execute time:

From 2020-01-09

To      2020-12-24

征募观察对象时间:

Recruiting time:

From 2020-01-09

To      2020-12-24

干预措施:

Interventions:

组别:

实验组

样本量:

150

Group:

Experimental group

Sample size:

干预措施:

经皮穴位电刺激

干预措施代码:

Intervention:

Transcutaneous Electrical Acupoint Stimulation

Intervention code:

组别:

对照组

样本量:

150

Group:

Control group

Sample size:

干预措施:

非经皮穴位电刺激

干预措施代码:

Intervention:

No Transcutaneous Electrical Acupoint Stimulation

Intervention code:

样本总量 Total sample size : 300

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

河南省

市(区县):

郑州市

Country:

China

Province:

He'nan

City:

Zhengzhou

单位(医院):

河南中医药大学第一附属医院

单位级别:

三甲医院

Institution/hospital:

The First Affiliated Hospital of Henan University of Chinese Medicine

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

恶心

指标类型:

次要指标

Outcome:

Nausea

Type:

Secondary indicator

测量时间点:

术后第二天下午;术后第三天下午

测量方法:

视觉模拟评分法

Measure time point of outcome:

the second afternoon of postoperative: the third afternoon of postoperative

Measure method:

Visual Analogue Scale (VAS)

指标中文名:

呕吐

指标类型:

次要指标

Outcome:

Vomiting

Type:

Secondary indicator

测量时间点:

术后第二天下午;术后第三天下午

测量方法:

视觉模拟评分法

Measure time point of outcome:

the second afternoon of postoperative: the third afternoon of postoperative

Measure method:

Visual Analogue Scale (VAS)

指标中文名:

术后PONV发生率

指标类型:

主要指标

Outcome:

Incidence of first Index of PONV

Type:

Primary indicator

测量时间点:

术后第二天下午;术后第三天下午

测量方法:

视觉模拟评分法

Measure time point of outcome:

the second afternoon of postoperative: the third afternoon of postoperative

Measure method:

Visual Analogue Scale (VAS)

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 50
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

简单随机的分配方法

Randomization Procedure (please state who generates the random number sequence and by what method):

simple random sampling

盲法:

No

Blinding:

No

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

医院科研部

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Scientific research department of the hospital

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例报告表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case report forum

数据管理委员会:

Data Managemen Committee:

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above